http://health.einnews.com/news/head-and-neck-cancerConstantly updated news and information about healthcare industry. http://health.einnews.com/news.php?wid=191860990 7 Oct 2008 11:34 GMT ... that revenue. It was drawn to ImClone because of Erbitux, which treats colorectal and head and neck cancers and could be approved for expanded uses, as well as by other drugs in ... http://health.einnews.com/news.php?wid=191858564 7 Oct 2008 10:56 GMT ... of Erbitux. The government has since approved Erbitux for use in treating colon and head and neck cancers. The sale of the company to Lilly means a billion-dollar payday for former rival ... http://health.einnews.com/news.php?wid=191845932 7 Oct 2008 07:23 GMT ... loses patent protection in 2012. Erbitux, which is approved to treat colon cancer and head and neck cancer, is ImClone's only marketed product, and generated $1.3 billion in sales last year. Part ... http://health.einnews.com/news.php?wid=191838595 7 Oct 2008 06:11 GMT ... replace that revenue. It was drawn to ImClone by Erbitux, which treats colorectal and head and neck cancers and could be approved for expanded uses, as well as by other drugs in ... http://health.einnews.com/news.php?wid=191827497 7 Oct 2008 04:56 GMT ... replace that revenue. It was drawn to ImClone, by Erbitux, which treats colorectal and head and neck cancers and could be approved for expanded uses, as well as by other drugs in ... http://health.einnews.com/news.php?wid=191815670 7 Oct 2008 04:14 GMT ... replace that revenue. It was drawn to ImClone, by Erbitux, which treats colorectal and head and neck cancers and could be approved for expanded uses, as well as by other drugs in ... http://health.einnews.com/news.php?wid=191812737 7 Oct 2008 04:00 GMT ... and Co's (LLY.N: Bristol-Myers, which co-markets ImClone's lucrative Erbitux treatment for colon cancer and head and neck cancer, said it was in the best interest of shareholders not to raise its previous ... http://health.einnews.com/news.php?wid=191811431 7 Oct 2008 03:55 GMT ... Leonidas Koniaris and colleagues at the University of Miami School of Medicine reviewed all head and neck cancer cases in Florida between 1998 and 2002. By mining information from the Florida Cancer ... http://health.einnews.com/news.php?wid=191809192 7 Oct 2008 03:35 GMT ... and most promising - new drug is Erbitux. It's already used to treat colorectal, head and neck cancers and was marketed by Lilly competitor Bristol-Myers. "We are very confident that this acquisition ... http://health.einnews.com/news.php?wid=191808885 7 Oct 2008 03:34 GMT ... replace that revenue. It was drawn to ImClone, by Erbitux, which treats colorectal and head and neck cancers and could be approved for expanded uses, as well as by other drugs in ... http://health.einnews.com/news.php?wid=191808495 7 Oct 2008 03:32 GMT ... of the Lilly deal. The deal will add Erbitux, a treatment for colorectal and head and neck cancers, to Lilly's portfolio of cancer drugs. They include the lung cancer and mesothelioma treatment ... http://health.einnews.com/news.php?wid=191804948 7 Oct 2008 03:18 GMT ... replace that revenue. It was drawn to ImClone, by Erbitux, which treats colorectal and head and neck cancers and could be approved for expanded uses, as well as by other drugs in ... http://health.einnews.com/news.php?wid=191799306 7 Oct 2008 02:37 GMT We estimate that financial leverage will remain well within the guideline of less than 1.5x adjusted debt to EBITDA and funds from operations to ... http://health.einnews.com/news.php?wid=191799302 7 Oct 2008 02:37 GMT ... in breast, prostate, pancreatic, colon, liver and head and neck cancers, as well as sarcoma, with Phase III ... ERBITUX in combination with radiation therapy in head and neck cancer patients with a history of coronary artery ... http://health.einnews.com/news.php?wid=191798059 7 Oct 2008 02:33 GMT ... and Merck KGaA outside the U.S. for the treatment of advanced colorectal and refractory head and neck cancers. The most advanced project in ImClone's R&D portfolio, IMC-1121B, is under investigation for breast ...